Crohn's Colitis Professional

Through the Looking Glass: Managing IBD Care for Diverse Patient Populations

Through the Looking Glass: Managing IBD Care for Diverse Patient Populations
RestartResume

Learning Objectives:
Upon completion of the program, participants should be able to:

1) Describe and discredit current myths about Inflammatory Bowel Disease (IBD) related to certain populations such as Black/African American, Hispanic/Latino, Asian and the Ashkenazi Jewish population.

2) Leverage current case studies, research studies, and Crohn’s and Colitis resources to demonstrate the diversity of the IBD population.

3) Discuss evidence-based differences in treatment patterns for different IBD patient populations including Black/African American, Hispanic/Latino, and Asian.

4) Identify differences in disease perception and self-management within IBD patient populations.

  • Overview

    Speakers & Disclosures:

    • Dr. Lisa Malter:
      • Ad Boards: AbbVie, BMS, Takeda, Janssen, Merck, Takeda
      • Medical Education Grants: AbbVie, Janssen, Pfizer, Takeda

    This activity is supported by an independent educational grant from Bristol Myers Squibb.

Facebook Comments

Register

We’re glad to see you’re enjoying Crohn's Colitis Professional…
but how about a more personalized experience?

Register for free